News
News Center Events Publications

MGI Presents Genetic Sequencers and Laboratory Automation Systems at Hospitalar in Brazil

2019-06-05


Sao Paulo, May 24, 2019 – MGI, a subsidiary of global genomics leader BGI Group, is bringing its genetic sequencing and laboratory automation platforms to Brazil, where the company participated in the Hospitalar conference May 21-24.



MGI showcased its innovation in next generation sequencing technology and presented along with its early adopter in the local market, the Oswaldo Cruz Foundation (Fiocruz). Based on its proprietary technology, MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medical diagnosis and healthcare.


At Hospitalar, MGI exhibited its MGISEQ-200RS and MGISEQ-2000RS genetic sequencers, MGISP-960 sample prep system and MGIFLP modular workstation.


MGISEQ-200RS and MGISEQ-2000RS genetic sequencers based on MGI’s DNBSEQTM sequencing technology combine low error accumulation, low duplicate reads, high signal intensity in the 2nd strand detection, and high uniformity to higher GC rich region, which can improve the detection accuracy and achieve more efficient sequencing.


MGISP-960 High-throughput Automated Sample Preparation System is a flexible, fully automated workstation with a built-in NGS sample-prep process and tailored workflows to satisfy unique needs of individual labs. Applications are available for genomics, cell biology, drug discovery, protein science, analytical chemistry and more.


MGIFLP is a modular NGS workstation independently developed by MGI. It integrates the entire NGS process into one step and provides clinical personnel and researchers a fully automated solution, from sample to sequencing report.


MGI’s sequencing technology can support efforts by BGI and partners in Latin America to advance healthcare, transgenic and scientific research. BGI Group also has partnered with the Oswaldo Cruz Foundation on scientific cooperation. BGI and four other hospital, research and technology partners in China signed an agreement with Fiocruz in February 2018 to work together to set up two Brazil-China Centers for Research and Prevention of Infectious Diseases, one in Brazil and one in China. The centers aim to address basic and translational research applied to health, focusing on the prevention and control of epidemics and other infectious diseases


4000-966-988Hot Line

Wechat Wechat